+36.1%
MRNA vs LH
+58.7%
-22.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | LH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.5% | +3.9% | +4.2% |
| 7D | -1.1% | -4.7% | +3.6% | +2.7% |
| 30D | +126.1% | -3.5% | +129.6% | +134.2% |
| 3M | +190.0% | +17.7% | +172.3% | +170.3% |
| 6M | +157.2% | +15.8% | +141.5% | +141.5% |
| YTD | +388.2% | +25.1% | +363.1% | +337.7% |
| 1Y | +467.0% | +12.5% | +454.5% | +436.3% |
| 3Y | +36.1% | +59.8% | -23.7% | +10.1% |
| All | +36.1% | +58.7% | -22.6% | +10.1% |
Cumulative growth
Daily Returns
Daily percentage return beside LH.
Daily Out/Under-Performance
Portfolio return minus LH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded LH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling